Is It Time for Australia to Reassess Its Legislation on Human Embryo Experimentation?


Journal

Journal of law and medicine
ISSN: 1320-159X
Titre abrégé: J Law Med
Pays: Australia
ID NLM: 9431853

Informations de publication

Date de publication:
Mar 2022
Historique:
entrez: 1 4 2022
pubmed: 2 4 2022
medline: 5 4 2022
Statut: ppublish

Résumé

The United Kingdom Warnock Committee (1984) was a landmark contributor to the ethics and law governing human embryo experimentation. It recommended a time limit up to 14 days of development after fertilisation within which such experimentation may take place, which mirrors the late 1970s' proposal of the United States Department of Health, Education, and Welfare Ethics Advisory Board (EAB). This study analyses the EAB's and the Warnock Committee's reasoning and conclusions regarding what constitutes ethical behaviour towards the human embryo. Current embryology and recently created embryo-like structures are considered. After the Warnock Report, several Australian Federal and State committees in Australia investigated the ethics which should guide experimentation on human embryos. The reports of these Australian committees are reviewed and the potential influence of both earlier committees on their deliberations is discussed. The rationale informing current Australian law governing human embryo experimentation is examined. Considering current more advanced knowledge of embryology, it is concluded that this legislation should be reassessed.

Identifiants

pubmed: 35362296

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

279-296

Déclaration de conflit d'intérêts

None.

Auteurs

Francis J OKeeffe (FJ)

School of Medicine, Sydney, The University of Notre Dame Australia, Darlinghurst, NSW, Australia.

Margaret Somerville (M)

School of Medicine, Sydney, The University of Notre Dame Australia, Darlinghurst, NSW, Australia.

George L Mendz (GL)

School of Medicine, Sydney, The University of Notre Dame Australia, Darlinghurst, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH